- 血液・腫瘍内科ホームページ >
- ホーム >
- 研究活動 >
- Publication List >
- 2001 年
2001 年
150. Kimura, S., Iyama, S., Yamaguchi, Y. and Kanakura, Y.
Homogenous enzyme immunoassay for cyclosporine in whole blood using
the EMIT 2000 cyclosporine specific assay with the COBAS MIRA-plus
analyzer. J
Clin Lab Anal. 15(6):319-23, 2001.
149. Suehisa, E., Nomura, T., Kawasaki, T. and Kanakura, Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagulation and Fibrinolysis 12(2):95-99, 2001.
148. Tatsumi, M., Kitayama, H., Sugahara, H., Tokita, N., Nakamura, H., Kanakura, Y. and Nishimura, T. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkinﾕs lymphoma. the Journal of Nuclear Medicine 42（4）：601-608，2001.
147. Nishimura, J., Phillips, K.L., Ware, R.E., Hall, S., Wilson, L., Gentry, T.L., Howard, T.A., Murakami, Y., Shibano, M., Machii, T., Gilboa, E., Kanakura, Y., Takeda, J., Kinoshita, T., Rosse, W.F. and Smith, C.A. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype. Blood 97(10):3004-3010, 2001.
146. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Iwatani, Y. and Kanakura, Y. Association between the prevalence of antibodies to β2-glycoprotein・, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clinical Chemistry 47(6):1008-1015, 2001.
145. Suehisa, E., Toku, M., Kawasaki, T. and Kanakura, Y. Measurement of a newly developed thrombomodulin addition activated partial thromboplastin time assay in patients with deep venous thrombosis. Haemostasis 31:26-31, 2001.
144. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Kitani, T., Iwatani, Y. and Kanakura, Y. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. British Journal of Haematology 114:546-553, 2001.
143. Kabutomori, O., Kanakura, Y. and Iwatani, Y. Increase in platelet-large cell ratio in chronic myeloid leukemia. Leukemia Research 25:873, 2001.
142. Kawasaki, A., Matsumura, I., Miyagawa, J., Ezoe, S., Tanaka, H., Terada, Y., Tatsuka, M., Machii, T., Miyazaki, H., Furukawa, Y. and Kanakura, Y. Downregulation of an AIM-1 Kinase couples with megakaryocytic polyploidization of human hematopoietic cells.
The Journal of Cell Biology 152(2):275-287, 2001.
141. Takahashi, K., Iwase, M., Yamashita, K., Tatsumoto, Y., Ue, H., Kuratsune, H., Shimizu, A. and Takeda M. The elevation of natural killer cell activity induced by laughter in a crossover designed study. International Journal of Molecular Medicine 8:645-650, 2001.
140. Fukuda, M., Ikuta, K., Yanagihara, K., Tajima, M., Kuratsune, H., Kurata, T. and Sairenji, T. Effect of TGF-β1 on the cell growth and EBV reactivation in EBV-infected epithelial cell lines. Virology 288(1):109-18, 2001.
149. Suehisa, E., Nomura, T., Kawasaki, T. and Kanakura, Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagulation and Fibrinolysis 12(2):95-99, 2001.
148. Tatsumi, M., Kitayama, H., Sugahara, H., Tokita, N., Nakamura, H., Kanakura, Y. and Nishimura, T. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkinﾕs lymphoma. the Journal of Nuclear Medicine 42（4）：601-608，2001.
147. Nishimura, J., Phillips, K.L., Ware, R.E., Hall, S., Wilson, L., Gentry, T.L., Howard, T.A., Murakami, Y., Shibano, M., Machii, T., Gilboa, E., Kanakura, Y., Takeda, J., Kinoshita, T., Rosse, W.F. and Smith, C.A. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype. Blood 97(10):3004-3010, 2001.
146. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Iwatani, Y. and Kanakura, Y. Association between the prevalence of antibodies to β2-glycoprotein・, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clinical Chemistry 47(6):1008-1015, 2001.
145. Suehisa, E., Toku, M., Kawasaki, T. and Kanakura, Y. Measurement of a newly developed thrombomodulin addition activated partial thromboplastin time assay in patients with deep venous thrombosis. Haemostasis 31:26-31, 2001.
144. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Kitani, T., Iwatani, Y. and Kanakura, Y. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. British Journal of Haematology 114:546-553, 2001.
143. Kabutomori, O., Kanakura, Y. and Iwatani, Y. Increase in platelet-large cell ratio in chronic myeloid leukemia. Leukemia Research 25:873, 2001.
142. Kawasaki, A., Matsumura, I., Miyagawa, J., Ezoe, S., Tanaka, H., Terada, Y., Tatsuka, M., Machii, T., Miyazaki, H., Furukawa, Y. and Kanakura, Y. Downregulation of an AIM-1 Kinase couples with megakaryocytic polyploidization of human hematopoietic cells.
The Journal of Cell Biology 152(2):275-287, 2001.
141. Takahashi, K., Iwase, M., Yamashita, K., Tatsumoto, Y., Ue, H., Kuratsune, H., Shimizu, A. and Takeda M. The elevation of natural killer cell activity induced by laughter in a crossover designed study. International Journal of Molecular Medicine 8:645-650, 2001.
140. Fukuda, M., Ikuta, K., Yanagihara, K., Tajima, M., Kuratsune, H., Kurata, T. and Sairenji, T. Effect of TGF-β1 on the cell growth and EBV reactivation in EBV-infected epithelial cell lines. Virology 288(1):109-18, 2001.